← Leaderboards
Philip D Gregory
Sangamo Biosciences, Inc.
$1,225,548
Attributed
$1,225,548
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $367.7K · FY2011–15$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$1,225,548 · 2
By mechanism
U19$1,061,941 · 1
R44$163,607 · 1
Top collaborators
No co-investigators on record.
Most similar at Sangamo Biosciences, Inc.
Same institution · by research overlap
- Fyodor D Urnov$2,470,630
Others in their field
Top investigators on “Epidemiology”
- David Heimbrook · Leidos Biomedical Research, Inc.$390,770,069
- George R Seage · Abt Associates, Inc.$299,251,523
- Jeffrey P Krischer · University Of South Florida$264,076,260
- Barbara Driver · Westat, Inc.$221,167,491
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$206,739,528
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
EpidemiologyAcquired Immunodeficiency SyndromeEngineeringEnzymesAllogenicAnimalsAffectAblationAllelesAcademiaBloodBone MarrowBone Marrow TransplantationCcr5 GeneAutologous Bone Marrow TransplantationCellsCell TransplantsBackClinical EfficacyClinically RelevantClinical PracticeBasic ScienceDna Repair PathwayGenerations
Grant awards (6)
ZFN-Modified Stem Cells for HIV Eradication$189,783
U19 · FY2015 · AI · contact PI
ZFN-Modified Stem Cells for HIV Eradication$172,991
U19 · FY2014 · AI · contact PI
ZFN-Modified Stem Cells for HIV Eradication$183,191
U19 · FY2013 · AI · contact PI
ZFN-Modified Stem Cells for HIV Eradication$148,321
U19 · FY2012 · AI · contact PI
ZFN-Modified Stem Cells for HIV Eradication$367,655
U19 · FY2011 · AI · contact PI
Targeted VEGF Methylation: Novel Cancer Therapy$163,607
R44 · FY2003 · CA